EU Regulators Give Positive Opinion to Revolution Medicines Pancreatic Cancer Treatment
The European Medicines Agency’s Committee for Medicinal Products for Human Use adopted a positive opinion for Rasonque, also known generically as daraxonrasib, for adults.